1 Jan 2014 Jahr - $100 million from Alexion Pharmaceuticals
Beschreibung:
Alexion Pharmaceuticals paid Moderna $100 million for ten product options to develop rare disease treatments, including for Crigler-Najjar syndrome, using Moderna's mRNA therapeutics platform
Zugefügt zum Band der Zeit:
Datum: